Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of BJ human fibroblasts treated with doxorubicin or abemaciclib compared to vehicle-treated counterpart


ABSTRACT: This experiment follows the transcriptional response of human fibroblasts (BJ) to two different drug treatments (doxorubicin and abemaciclib) in comparison to treatment with vehicle (water). The two drugs are used in cancer care and their mechanism of action entails proliferative arrest. Doxorubicin is a member of the anthracycline family and acts as a topoisomerase II inhibitor. Abemaciclib is an inhibitor of the Cyclin Dependent Kinases (CDK) 4/6 which arrest cell cycle at the G1/S phase.

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Homo sapiens

SUBMITTER: Marco Demaria 

PROVIDER: E-MTAB-7642 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2013-08-05 | E-GEOD-46489 | biostudies-arrayexpress
2013-08-05 | E-GEOD-46508 | biostudies-arrayexpress
2020-05-01 | E-MTAB-7669 | biostudies-arrayexpress
2023-11-30 | E-MTAB-11247 | biostudies-arrayexpress
2013-07-04 | E-GEOD-41402 | biostudies-arrayexpress
2015-12-17 | E-GEOD-74398 | biostudies-arrayexpress
2015-08-28 | E-GEOD-62890 | biostudies-arrayexpress
2015-12-31 | E-GEOD-68416 | biostudies-arrayexpress
2021-11-03 | PXD017297 | Pride
2021-11-03 | PXD017164 | Pride